Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute research scientist Noll Campbell, PharmD, M.S., recently contributed to a study that made national headlines and provided more evidence that anticholinergic medications are linked to cognitive decline.

The results from the study, led by researchers at the University of California San Diego School of Medicine, were published in Neurology. The authors concluded that anticholinergics are associated with an increased risk of cognitive decline regardless of the presence of genetic or biomarker risk factors for Alzheimer’s disease.

Dr. Campbell consulted on the study, providing perspective on the data based on similar studies he has been involved with at Regenstrief and Indiana University School of Medicine.  He is listed as an author on the paper.

The past research conducted by Dr. Campbell and his colleagues also provides evidence establishing a link between the common type of medication and cognitive decline. He is now leading a clinical trial to determine if deprescribing anticholinergics improves cognition, which could in turn delay or prevent dementia.

In addition to his role as a research scientist at Regenstrief Institute, Dr. Campbell is an assistant professor of pharmacy practice at the Purdue University College of Pharmacy.

Related Influence

Jul 07, 2021 • Influence
Algorithm developed by Regenstrief/Merck collaboration hailed as promising research tool
A natural language processing (NLP) algorithm to identify patients with chronic cough, created and validated by Regenstrief Institute, Indiana University and Merck & Co. research scientists, is being recognized for its ingenuity and its potential.   The paper describing the algorithm’s development, Identifying and Characterizing a Chronic Cough Cohort Through Electronic Health Records, was published in the June 2021 edition of Chest Journal, along with an editorial written…
Continue Reading >
Jun 22, 2021 • Influence
Regenstrief experts share cancer-related research as part of IU Simon Cancer Center Series
Two Regenstrief research scientists who focus on cancer research are sharing their knowledge in the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s monthly series called “Simon Says.”  The monthly virtual series was created to better connect cancer experts with the community, giving people the opportunity to hear about the latest research and ask questions.   [caption…
Continue Reading >